18
Participants
Start Date
March 14, 2022
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2025
Methylphenidate Hydrochloride
Participants will receive twice daily doses of Methylphenidate Hydrochloride four hours apart. There will be three dosage schedules, determined based on three weight ranges (20-30kg; 30-40kg; ≥40kg). For children weighing 20-30kg, the maximum daily dose will be 20mg. For children weighing 30-40kg, the maximum daily dose will be 30mg. For children weighing ≥40kg, the maximum daily dose will be 40mg.
Placebo
Participants will receive twice daily doses of placebo capsules. Gelatine placebo capsules will contain hypromellose, an inert substance.
Murdoch Children's Research Institute, Parkville
Lead Sponsor
Murdoch Childrens Research Institute
OTHER